journal article·2025-09-10

Light-Activated CD36-Targeted Cuproptosis Triggers Metabolic-Immune Synergy for Precision Breast Cancer Therapy

Shiwen Wang, Ying Shen, Binbin Hu, Qiping Wu, Nanzhou Wang, Zichao Wang, Zifeng Zhang, Yujie Li, Jianhui Jiang

ACS Applied Materials & Interfaces· Volume 17· Issue 36
Publisher page

Abstract

Breast cancer therapy confronts dual challenges of metabolic plasticity-driven drug resistance and immunosuppression. To address this, we developed DCP-TPP, a therapeutic nanoplatform that integrates dysregulation of copper homeostasis and lipid metabolism for precise breast cancer therapy. Leveraging the overexpression of cluster of differentiation 36 (CD36) in breast cancer cells, DCP-TPP employs fatty acid camouflage (PCM) to deliver disulfiram (DSF) and photothermal Cu 3 BiS 3 to cancer cells and features triphenylphosphonium (TPP) modification for targeted mitochondrial drug delivery. Near-infrared (NIR) irradiation triggers the phase transition of DCP-TPP’s outer layer, inducing spatiotemporal release of DSF to liberate copper ions from inert Cu 3 BiS 3, thereby generating diethyldithiocarbamate–copper complex (CuET). This disrupts copper homeostasis and induces cuproptosis, which subsequently triggers S -acetyltransferase (DLAT) aggregation, impairing tricarboxylic acid (TCA) cycle flux, acetyl-CoA production, ATP citrate lyase (Acly)-dependent lipogenesis, and ultimately collapses mitochondrial oxidative phosphorylation. Multiomics profiling revealed oleic acid depletion, arachidonic acid oxidation, and glutathione exhaustion, collectively amplifying metabolic collapse. DCP-TPP-induced cell death enhanced dendritic cell (DC) activation and CD8 + T cell infiltration. In breast cancer models, DCP-TPP achieved 90.9% tumor suppression, with 60% of mice resisting rechallenge. By transforming lipid metabolic dependency into a therapeutic vulnerability and coupling it with copper ion toxicity, DCP-TPP offers a promising strategy for breast cancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer, Lipids, and Metabolism · Cancer, Hypoxia, and Metabolism · Ferroptosis and cancer prognosis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biomedical Sciences

Hunan University

Center for Bioanalytical Chemistry, Hefei National Laboratory of Physical Science at Microscale

University of Science and Technology of China

Departments of Colorectal Surgery

Sun Yat-sen University Cancer Center

State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer

Henan Provincial Key Laboratory of Nanocomposites and Applications, Institute of Nanostructured Functional Materials

Huanghe Science and Technology College

Institute of Biomedical Engineering, College of Life Sciences

Qingdao University

State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Life Science and Technology

Jinan University

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (35)

Show source-provided references
1. 10.3390/cancers1112201210.3390/cancers11122012 ↗
2. 10.1038/nature2079110.1038/nature20791 ↗
3. 10.1016/j.celrep.2019.11.00810.1016/j.celrep.2019.11.008 ↗
4. 10.1016/j.cmet.2023.09.01210.1016/j.cmet.2023.09.012 ↗
5. 10.1038/s41392-022-01229-y10.1038/s41392-022-01229-y ↗
6. 10.1038/s41467-023-41757-x10.1038/s41467-023-41757-x ↗
7. 10.1021/acsnano.3c0136910.1021/acsnano.3c01369 ↗
8. 10.1002/adma.20240497110.1002/adma.202404971 ↗
9. 10.1002/smtd.20220037910.1002/smtd.202200379 ↗
10. 10.1002/adma.20221226710.1002/adma.202212267 ↗
11. 10.1016/j.cell.2025.03.03610.1016/j.cell.2025.03.036 ↗
12. 10.1038/s41467-020-18565-810.1038/s41467-020-18565-8 ↗
13. 10.1038/s41467-022-34357-810.1038/s41467-022-34357-8 ↗
14. 10.1038/s41388-017-0093-z10.1038/s41388-017-0093-z ↗
15. 10.1039/C7CC02555F10.1039/C7CC02555F ↗
16. 10.1016/j.ijbiomac.2023.12732410.1016/j.ijbiomac.2023.127324 ↗
17. 10.1021/acsnano.4c1545610.1021/acsnano.4c15456 ↗
18. 10.1002/smll.20240899610.1002/smll.202408996 ↗
19. 10.3945/an.115.00897910.3945/an.115.008979 ↗
20. 10.1002/anie.20241567110.1002/anie.202415671 ↗
21. 10.1002/anie.20231564210.1002/anie.202315642 ↗
22. 10.1021/acsnano.0c0884810.1021/acsnano.0c08848 ↗
23. 10.1021/acsnano.3c1017310.1021/acsnano.3c10173 ↗
24. 10.1038/nature2501610.1038/nature25016 ↗
25. 10.1016/j.jhep.2023.11.02310.1016/j.jhep.2023.11.023 ↗
26. 10.1016/j.nantod.2022.10145910.1016/j.nantod.2022.101459 ↗
27. 10.1002/adma.20230426210.1002/adma.202304262 ↗
28. 10.1016/j.freeradbiomed.2017.07.01010.1016/j.freeradbiomed.2017.07.010 ↗
29. 10.1186/s12951-023-01951-x10.1186/s12951-023-01951-x ↗
30. 10.1002/advs.20241112210.1002/advs.202411122 ↗
31. 10.1016/j.mtbio.2025.10174510.1016/j.mtbio.2025.101745 ↗
32. 10.1038/s41589-022-01159-410.1038/s41589-022-01159-4 ↗
33. 10.1186/s10020-025-01125-510.1186/s10020-025-01125-5 ↗
34. 10.1126/science.abi749510.1126/science.abi7495 ↗
35. 10.1084/jem.2023182010.1084/jem.20231820 ↗